These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36010602)

  • 1. SARS-CoV-2 Spike Does Not Possess Intrinsic Superantigen-like Inflammatory Activity.
    Amormino C; Tedeschi V; Paldino G; Arcieri S; Fiorillo MT; Paiardini A; Tuosto L; Kunkl M
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
    Noval Rivas M; Porritt RA; Cheng MH; Bahar I; Arditi M
    Front Immunol; 2022; 13():941009. PubMed ID: 35874696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro.
    Cheng MH; Porritt RA; Rivas MN; Krieger JM; Ozdemir AB; Garcia G; Arumugaswami V; Fries BC; Arditi M; Bahar I
    Structure; 2021 Sep; 29(9):951-962.e3. PubMed ID: 33930306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.
    Porritt RA; Paschold L; Rivas MN; Cheng MH; Yonker LM; Chandnani H; Lopez M; Simnica D; Schultheiß C; Santiskulvong C; Van Eyk J; McCormick JK; Fasano A; Bahar I; Binder M; Arditi M
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33705359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome.
    Porritt RA; Paschold L; Noval Rivas M; Hongying Cheng M; Yonker LM; Chandnani H; Lopez M; Simnica D; Schultheiß C; Santiskulvong C; Van Eyk J; Fasano A; Bahar I; Binder M; Arditi M
    bioRxiv; 2020 Nov; ():. PubMed ID: 33200133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of peripheral immunophenotypes of multisystem inflammatory syndrome in children.
    Morita A; Hosaka S; Imagawa K; Ishiodori T; Nozaki Y; Murakami T; Takada H
    Clin Immunol; 2022 Mar; 236():108955. PubMed ID: 35150919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations.
    Cheng MH; Zhang S; Porritt RA; Arditi M; Bahar I
    bioRxiv; 2020 May; ():. PubMed ID: 32511374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
    Conway SR; Lazarski CA; Field NE; Jensen-Wachspress M; Lang H; Kankate V; Durkee-Shock J; Kinoshita H; Suslovic W; Webber K; Smith K; Cohen JI; Burbelo PD; Zhang A; Teach SJ; Ibeh T; Delaney M; DeBiasi RL; Keller MD; Bollard CM
    Front Immunol; 2021; 12():793197. PubMed ID: 35116027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children.
    Kouo T; Chaisawangwong W
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33844652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children.
    Lam KP; Chiñas M; Julé AM; Taylor M; Ohashi M; Benamar M; Crestani E; Son MBF; Chou J; Gebhart C; Chatila T; Newburger J; Randolph A; Gutierrez-Arcelus M; Henderson LA
    Clin Immunol; 2022 Oct; 243():109106. PubMed ID: 36049601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children.
    Avcu G; Arslan SY; Soylu M; Bilen NM; Bal ZS; Cicek C; Kurugol Z; Ozkinay F
    Viral Immunol; 2022 Dec; 35(10):681-689. PubMed ID: 36534467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
    Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.
    Butters C; Benede N; Moyo-Gwete T; Richardson SI; Rohlwink U; Shey M; Ayres F; Manamela NP; Makhado Z; Balla SR; Madzivhandila M; Ngomti A; Baguma R; Facey-Thomas H; Spracklen TF; Day J; van der Ross H; Riou C; Burgers WA; Scott C; Zühlke L; Moore PL; Keeton RS; Webb K
    Clin Immunol; 2024 Feb; 259():109877. PubMed ID: 38141746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells.
    Gaglione SA; Rosales TJ; Schmidt-Hong L; Baker BM; Birnbaum ME
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2406615121. PubMed ID: 39042676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal expansion of TCR Vbeta 21.3
    Moreews M; Le Gouge K; Khaldi-Plassart S; Pescarmona R; Mathieu AL; Malcus C; Djebali S; Bellomo A; Dauwalder O; Perret M; Villard M; Chopin E; Rouvet I; Vandenesh F; Dupieux C; Pouyau R; Teyssedre S; Guerder M; Louazon T; Moulin-Zinsch A; Duperril M; Patural H; Giovannini-Chami L; Portefaix A; Kassai B; Venet F; Monneret G; Lombard C; Flodrops H; De Guillebon JM; Bajolle F; Launay V; Bastard P; Zhang SY; Dubois V; Thaunat O; Richard JC; Mezidi M; Allatif O; Saker K; Dreux M; Abel L; Casanova JL; Marvel J; Trouillet-Assant S; Klatzmann D; Walzer T; Mariotti-Ferrandiz E; Javouhey E; Belot A
    Sci Immunol; 2021 May; 6(59):. PubMed ID: 34035116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence.
    Filippatos F; Tatsi EB; Michos A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry
    Cheng MH; Porritt RA; Rivas MN; Krieger JM; Ozdemir AB; Garcia G; Arumugaswami V; Fries BC; Arditi M; Bahar I
    bioRxiv; 2020 Nov; ():. PubMed ID: 33269352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
    Anderson EM; Diorio C; Goodwin EC; McNerney KO; Weirick ME; Gouma S; Bolton MJ; Arevalo CP; Chase J; Hicks P; Manzoni TB; Baxter AE; Andrea KP; Burudpakdee C; Lee JH; Vella LA; Henrickson SE; Harris RM; Wherry EJ; Bates P; Bassiri H; Behrens EM; Teachey DT; Hensley SE
    J Pediatric Infect Dis Soc; 2021 May; 10(5):669-673. PubMed ID: 33263756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.